Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BMY | AMGN | VRTX | ||
| Company | Bristol-Myers Squibb Company | Amgen Inc | Vertex Pharmaceutic | ||
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | ||
| Open | 58.16 | 288.18 | 454.24 | ||
| High | 58.22 | 288.83 | 455.43 | ||
| Low | 57.47 | 284.14 | 445.00 | ||
| Last | 57.78 | 285.72 | 445.96 | ||
| Change | -0.10 | -2.15 | -5.27 | ||
| % Change | -0.17% | -0.75% | -1.17% | ||
| Volume | 965,295 | 344,407 | 154,309 | ||
| 20-Day Average Volume | 12,065,878 | 2,756,853 | 1,276,294 | ||
| Previous Close | 57.88 | 287.87 | 451.23 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 55.91 | 307.16 | 479.02 | ||
| 20-Day Raw Stochastic | 66.02% | 17.58% | 1.02% | ||
| 20-Day Relative Strength | 60.04% | 33.55% | 39.72% | ||
| Weighted Alpha | +25.16 | -0.53 | +16.45 | ||
| Today's Opinion | 100% Buy | 40% Sell | 8% Sell | ||
| Previous Opinion | 100% Buy | 40% Sell | 8% Sell | ||
| Last Month's Opinion | 88% Buy | 8% Buy | 8% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.97% since 11/14/24 | -3.75% since 11/14/24 | -7.84% since 11/14/24 | ||
| Low | 55.82 on 11/15/24 | 275.56 on 11/19/24 | 445.25 on 11/21/24 | ||
| High | 58.83 on 11/20/24 | 291.50 on 11/15/24 | 479.93 on 11/15/24 | ||
| 1-Month | |||||
| %Chg | +11.15% since 10/21/24 | -10.08% since 10/21/24 | -6.71% since 10/21/24 | ||
| Low | 51.81 on 10/28/24 | 275.56 on 11/19/24 | 445.25 on 11/21/24 | ||
| High | 61.08 on 11/11/24 | 328.25 on 11/08/24 | 519.88 on 11/08/24 | ||
| 3-Month | |||||
| %Chg | +19.59% since 08/21/24 | -13.47% since 08/21/24 | -8.25% since 08/21/24 | ||
| Low | 46.88 on 08/22/24 | 275.56 on 11/19/24 | 445.25 on 11/21/24 | ||
| High | 61.08 on 11/11/24 | 339.17 on 09/23/24 | 519.88 on 11/08/24 | ||
| 6-Month | |||||
| %Chg | +37.05% since 05/21/24 | -9.54% since 05/21/24 | +0.91% since 05/21/24 | ||
| Low | 39.35 on 07/05/24 | 275.56 on 11/19/24 | 435.57 on 05/30/24 | ||
| High | 61.08 on 11/11/24 | 346.85 on 07/25/24 | 519.88 on 11/08/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 117,390,888 | 154,739,632 | 116,204,808 | ||
| Shares Outstanding, K | 2,028,177 | 537,533 | 257,529 | ||
| Annual Sales | 45,006,000,000 | 28,190,000,000 | 9,869,200,000 | ||
| Annual Net Income | 8,025,000,000 | 6,717,000,000 | 3,619,600,000 | ||
| Last Quarter Sales | 11,892,000,000 | 8,503,000,000 | 2,771,900,000 | ||
| Last Quarter Net Income | 1,211,000,000 | 2,830,000,000 | 1,045,400,000 | ||
| 60-Month Beta | 0.44 | 0.60 | 0.39 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.80 on 10/31/24 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | ||
| Latest Earnings Date | 10/31/24 | 10/30/24 | 11/04/24 | ||
| Most Recent Dividend | 0.600 on 10/04/24 | 2.250 on 11/18/24 | N/A | ||
| Next Ex-Dividends Date | 10/04/24 | 11/18/24 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 49.77 | 14.57 | 0.00 | ||